Cargando…

Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols

Polycystic ovary syndrome (PCOS) is characterized by hormonal abnormalities that cause menstrual irregularity and reduce ovulation rate and fertility, associated to insulin resistance. Myo-inositol (cis-1,2,3,5-trans-4,6-cyclohexanehexol, MI) and D-chiro-inositol (cis-1,2,4-trans-3,5,6-cyclohexanehe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sortino, Maria A., Salomone, Salvatore, Carruba, Michele O., Drago, Filippo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463048/ https://www.ncbi.nlm.nih.gov/pubmed/28642705 http://dx.doi.org/10.3389/fphar.2017.00341

Ejemplares similares

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

The “Asthma-Polycystic Ovary Overlap Syndrome” and the Therapeutic Role of Myo-Inositol
por: Guarnieri, Gabriella, et al.
Publicado: (2023)

Quercetin and polycystic ovary syndrome
por: Ma, Congshun, et al.
Publicado: (2022)

Advancements in lead therapeutic phytochemicals polycystic ovary syndrome: A review
por: Luo, Er-Dan, et al.
Publicado: (2023)

Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2019)

Therapeutic Effect of Ecklonia cava Extract in Letrozole-Induced Polycystic Ovary Syndrome Rats
por: Yang, Hyun, et al.
Publicado: (2018)

Therapeutic Effects and Mechanisms of Herbal Medicines for Treating Polycystic Ovary Syndrome: A Review
por: Kwon, Chan-Young, et al.
Publicado: (2020)

Myo-inositol for insulin resistance, metabolic syndrome, polycystic ovary syndrome and gestational diabetes
por: DiNicolantonio, James J, et al.
Publicado: (2022)

Management of polycystic ovary syndrome among Indian women using myo‐inositol and D-chiro-inositol
por: Vyas, Lila, et al.
Publicado: (2022)

Evidence-Based and Patient-Oriented Inositol Treatment in Polycystic Ovary Syndrome: Changing the Perspective of the Disease
por: Laganà, Antonio Simone, et al.
Publicado: (2017)

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
por: Shan, Hongying, et al.
Publicado: (2022)

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
por: Yang, Hyun, et al.
Publicado: (2022)

Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells
por: Bucolo, Claudio, et al.
Publicado: (2012)

Ocular drug delivery: a clue from nanotechnology
por: Bucolo, Claudio, et al.
Publicado: (2012)

Impact of myo-inositol treatment in women with polycystic ovary syndrome in assisted reproductive technologies
por: Merviel, Philippe, et al.
Publicado: (2021)

Mesenchymal stem cells-derived exosomes as a promising new approach for the treatment of infertility caused by polycystic ovary syndrome
por: Izadi, Mahin, et al.
Publicado: (2022)

Rescue of Noradrenergic System as a Novel Pharmacological Strategy in the Treatment of Chronic Pain: Focus on Microglia Activation
por: Caraci, Filippo, et al.
Publicado: (2019)

Apixaban Enhances Vasodilatation Mediated by Protease-Activated Receptor 2 in Isolated Rat Arteries
por: Villari, Ambra, et al.
Publicado: (2017)

Comparing the Efficacy of Myo-Inositol Plus α-Lactalbumin vs. Myo-Inositol Alone on Reproductive and Metabolic Disturbances of Polycystic Ovary Syndrome
por: Kamenov, Zdravko, et al.
Publicado: (2023)

Metabolomic Insight into Polycystic Ovary Syndrome—An Overview
por: Rajska, Anna, et al.
Publicado: (2020)

Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach
por: Platania, Chiara B. M., et al.
Publicado: (2015)

MiR-185-5p Protects Against Angiogenesis in Polycystic Ovary Syndrome by Targeting VEGFA
por: Wei, Jingzan, et al.
Publicado: (2020)

Enoxacin ameliorates polycystic ovary syndrome by promoting the browning of white adipose tissue and restoring gut dysbiosis
por: Zhu, Wanlong, et al.
Publicado: (2022)

Potentials of curcumin against polycystic ovary syndrome: Pharmacological insights and therapeutic promises
por: Akter, Tanzina, et al.
Publicado: (2023)

New Therapeutic Approaches in Obesity and Metabolic Syndrome Associated with Polycystic Ovary Syndrome
por: Saleem, Fatima, et al.
Publicado: (2017)

Nutrients as novel therapeutic approaches for metabolic disturbances in polycystic ovary syndrome
por: Mansour, Asieh, et al.
Publicado: (2016)

Polycystic ovary syndrome: pathophysiology and therapeutic opportunities
por: Dong, Jiawen, et al.
Publicado: (2023)

Buspirone Counteracts MK-801-Induced Schizophrenia-Like Phenotypes through Dopamine D(3) Receptor Blockade
por: Torrisi, Sebastiano Alfio, et al.
Publicado: (2017)

Editorial: Insights in Experimental Pharmacology and Drug Discovery: 2021
por: Trostchansky, Andres, et al.
Publicado: (2022)

Mechanistic and therapeutic insight into the effects of cinnamon in polycystic ovary syndrome: a systematic review
por: Maleki, Vahid, et al.
Publicado: (2021)

Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate
por: Bucolo, Claudio, et al.
Publicado: (2015)

Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies
por: Zeng, Ling-Hui, et al.
Publicado: (2022)

Berberine—A Promising Therapeutic Approach to Polycystic Ovary Syndrome in Infertile/Pregnant Women
por: Ionescu, Oana-Maria, et al.
Publicado: (2023)

An update of polycystic ovary syndrome: causes and therapeutics options
por: Rababa’h, Abeer M., et al.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

1,25-Dihydroxyvitamin D inhibits hepatic diacyglycerol accumulation and ameliorates metabolic dysfunction in polycystic ovary syndrome rat models
por: Yuan, Xin, et al.
Publicado: (2023)

Myo-Inositol’s Role in Assisted Reproductive Technology: Evidence for Improving the Quality of Oocytes and Embryos in Patients With Polycystic Ovary Syndrome
por: Gupta, Deepti, et al.
Publicado: (2020)

Effects of inositol and alpha lipoic acid combination for polycystic ovary syndrome: A protocol for systematic review and meta-analysis
por: Lei, Wenwen, et al.
Publicado: (2020)

Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
por: Greff, Dorina, et al.
Publicado: (2023)

Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
por: Yumiceba, Verónica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v17otugheue12vsend327kn89p